Hudson Bay Capital Management’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $957K | Buy |
825,004
+55,004
| +7% | +$63.8K | ﹤0.01% | 666 |
|
|
2025
Q1 | $847K | Buy |
770,000
+55,000
| +8% | +$60.5K | ﹤0.01% | 613 |
|
|
2024
Q4 | $1.23M | Buy |
715,000
+79,000
| +12% | +$136K | ﹤0.01% | 542 |
|
|
2024
Q3 | $1.58M | Sell |
636,000
-34,000
| -5% | -$84.3K | 0.01% | 451 |
|
|
2024
Q2 | $1.62M | Buy |
670,000
+110,000
| +20% | +$266K | 0.01% | 443 |
|
|
2024
Q1 | $2.27M | Sell |
560,000
-4,400
| -0.8% | -$17.8K | 0.01% | 363 |
|
|
2023
Q4 | $2.17M | Buy |
564,400
+39,400
| +8% | +$151K | 0.01% | 373 |
|
|
2023
Q3 | $2.18M | Buy |
525,000
+130,000
| +33% | +$540K | 0.02% | 396 |
|
|
2023
Q2 | $1.9M | Buy |
395,000
+38,000
| +11% | +$183K | 0.01% | 451 |
|
|
2023
Q1 | $1.45M | Buy |
357,000
+117,000
| +49% | +$475K | 0.01% | 516 |
|
|
2022
Q4 | $1.3M | Buy |
+240,000
| New | +$1.3M | 0.01% | 626 |
|